CF vs LBRX · P/E 12, rev $4.21B vs $803.4M cap
CF Industries Holdings Inc (CF) versus LB Pharmaceuticals Inc Common Stock (LBRX) — a side-by-side from cached financials, not a winner call.
CF Industries Holdings Inc (CF) is a agricultural inputs company listed on US.
LB Pharmaceuticals Inc Common Stock (LBRX) is a biotechnology company listed on NASDAQ.
Latest reported CF revenue for 2026-06-30 was $4.21B. Net income was $1.54B. CF currently screens at market cap $14.98B and trailing P/E 12.2.
LBRX does not have a complete income-statement cache yet.
CF currently screens at market cap $14.98B and trailing P/E 12.2. LBRX currently screens at market cap $803.4M.
Not investment advice. Open the CF and LBRX stock pages for the full models.
Not investment advice.